Daily Ards Research Analysis
Genetic Mendelian randomization work maps causal genes and four druggable targets for sepsis-related ARDS, pointing to new therapeutic avenues. A neonatal ventilation meta-analysis suggests HFOV with volume guarantee may improve survival free of grade 2–3 BPD and shorten support, while a prospective C-ARDS study shows prone positioning improves RV function and oxygenation without guaranteed survival benefit.
Summary
Genetic Mendelian randomization work maps causal genes and four druggable targets for sepsis-related ARDS, pointing to new therapeutic avenues. A neonatal ventilation meta-analysis suggests HFOV with volume guarantee may improve survival free of grade 2–3 BPD and shorten support, while a prospective C-ARDS study shows prone positioning improves RV function and oxygenation without guaranteed survival benefit.
Research Themes
- Genetic target discovery for sepsis-related ARDS
- Ventilatory strategies and lung-protective approaches in infants
- Cardiopulmonary interactions and prone positioning in ARDS
Selected Articles
1. Identifying potential drug targets for sepsis-related adult respiratory distress syndrome through comprehensive genetic analysis and druggability assessment.
Using multiple Mendelian randomization frameworks across >100,000 participants and >10,000 cis-eQTLs, the authors mapped 50 genes causally linked to sepsis-related ARDS and highlighted four druggable targets (PSMA4, PDK2, RPS18, NDUFV3). They also confirmed a causal relationship between sepsis and ARDS (beta 1.80, SE 0.36, P<0.001).
Impact: This work provides an actionable shortlist of causal genes and druggable targets for sepsis-related ARDS, offering a roadmap for preclinical validation and therapeutic development.
Clinical Implications: While not immediately practice-changing, the targets (PSMA4, PDK2, RPS18, NDUFV3) prioritize pathways for drug development and may inform biomarker-driven stratification in future trials.
Key Findings
- Sepsis is causally associated with ARDS (beta 1.80, SE 0.36, P<0.001).
- SMR identified 677 cis-eQTL genes linked to sepsis; TSMR confirmed 72 as causally associated.
- Mediating and multivariate MR analyses implicated 50 cis-eQTL genes in sepsis-related ARDS.
- Four druggable targets were prioritized: PSMA4, PDK2, RPS18, and NDUFV3.
Methodological Strengths
- Multi-method Mendelian randomization (SMR, TSMR, mediating MR, MVMR) strengthens causal inference.
- Large-scale integration of >10,000 cis-eQTLs and >100,000 participants.
Limitations
- Relies on summary-level genetic data; residual pleiotropy and instrument validity may affect estimates.
- No functional or experimental validation of identified targets within the study.
Future Directions: Prioritize functional validation of PSMA4, PDK2, RPS18, and NDUFV3; develop perturbation models and early-phase trials to translate genetic causality into therapeutics.
BACKGROUND: Sepsis-related adult respiratory distress syndrome (ARDS) is a life-threatening condition characterised by a high mortality rate. This underscores the pressing requirement to identify and develop potential therapeutic targets for the severe condition. This study investigated the genetic predisposition to sepsis-related ARDS in this study. METHODS: We utilised summary-based Mendelian randomisation (SMR), two-sample MR (TSMR), mediating MR, and multivariate MR (MVMR) analysis to explore the genetic susceptibility of sepsis-related ARDS by integrating over 10 000 cis-expression quantitative trait loci (cis-eQTLs) and over 100 000 participants. Subsequently, we performed drug target analysis to identify potentially druggable cis-eQTL genes. RESULTS: The SMR analysis identified 677 cis-eQTL genes associated with sepsis. Further TSMR validation filtered 72 cis-eQTL genes causally associated with sepsis. Sepsis was causally associated with ARDS (beta = 1.80, standard error (SE) = 0.36, P < 0.001). After conducting the mediating MR and MVMR analysis, 50 cis-eQTL genes were reported to be causally associated with sepsis-related ARDS. Subsequent drug target analysis confirmed the role of four targets (PSMA4, PDK2, RPS18, and NDUFV3) as druggable genes for sepsis-related ARDS. CONCLUSIONS: Through an extensive analysis, we identified potential drug targets for sepsis-related ARDS. Additional research is imperative to substantiate our discoveries and to pave the way for the development of novel pharmaceuticals aimed at these specific targets.
2. High-frequency oscillatory ventilation with volume guarantee in infants: a systematic review.
Across 11 studies (including three RCTs; n=785), HFOV with volume guarantee increased survival free of grade 2–3 BPD versus HFOV alone (OR 3.15, 95% CI 1.66–5.98). Signals suggested shorter invasive ventilation and hospital stay and potential reductions in mortality and air leak, though overall BPD incidence was unchanged.
Impact: Synthesizing RCTs and observational data, this review informs neonatal ventilatory strategy by indicating potential benefits of HFOV-VG on clinically meaningful outcomes.
Clinical Implications: When HFOV is selected for preterm infants (<32 weeks GA), combining VG may improve survival free of severe BPD and shorten support, but practice should await confirmation from large multicenter RCTs.
Key Findings
- HFOV-VG increased survival free of grade 2–3 BPD versus HFOV alone (OR 3.15, 95% CI 1.66–5.98).
- No reduction in overall BPD incidence was observed compared with HFOV alone.
- Signals of shorter invasive ventilation and hospital stay, with potential reductions in mortality and air leak syndrome.
Methodological Strengths
- Includes randomized trials alongside controlled and observational studies, increasing robustness.
- Independent dual screening, data extraction, quality assessment, and quantitative meta-analysis.
Limitations
- Heterogeneity across study designs and populations; limited number of RCTs.
- Potential publication bias and lack of uniform definitions of outcomes.
Future Directions: Conduct adequately powered, multicenter RCTs to confirm effects of HFOV-VG on BPD grades, mortality, and ventilator days, and to define optimal settings.
BACKGROUND: This systematic review was designed to assess the efficacy and safety of high-frequency oscillatory ventilation (HFOV) combined with volume guarantee (VG) in infants compared with HFOV alone. METHODS: We searched for electronic databases to find studies using HFOV-VG or HFOV for respiratory support in infants from the database creation to October 20, 2024. Two evaluators independently screened the literature, extracted data, and evaluated quality. Meta-analysis was performed using Rev man 5.3 software on survival-free BPD at grades 2 and 3 (SF-BPD), the incidence of BPD, mortality, duration of invasive ventilation, length of hospital stays, and complications in both groups. RESULTS: The review included 11 studies (three randomized controlled trials, one non-randomized controlled trial, and seven observational studies) with 785 participants. Data analysis showed that HFOV-VG could increase SF-BPD in preterm infants (OR 3.15, 95%CI 1.66-5.98) without reducing the overall incidence of BPD compared with HFOV alone. HFOV-VG may offer advantages in shortening the duration of MV and total hospital stay, potentially reducing mortality and the incidence of air leak syndrome. CONCLUSIONS EXISTING: Studies showed that HFOV-VG had certain advantages in improving oxygenation and stable ventilation to protect neonatal lungs. HFOV-VG could increase SF-BPD in preterm infants with GA < 32 weeks without reducing the overall incidence of BPD compared with HFOV alone. IMPACT: Existing evidence suggested that HFOV-VG ventilation strategies could increase SF-BPD in preterm infants with GA < 32 weeks without reducing the overall incidence of BPD compared with HFOV alone. HFOV-VG ventilation strategy has certain advantages in improving oxygenation and stable ventilation to protect neonatal lungs. The effects of HFOV-VG vs. HFOV in neonates remain to be further validated by additional large sample, multicenter RCTs.
3. The Effect of Prone Position on Right Ventricular Functions in CARDS: Is Survival Predictable when Evaluated Through Transesophageal Echocardiography?
In a prospective cohort of 30 moderate-to-severe C-ARDS patients undergoing early prone positioning, TEE showed decreases in RVEDA/LVEDA and increases in TAPSE alongside improved oxygenation. However, these physiological improvements did not consistently translate into survival gains; higher static compliance (Cstat) appeared linked to better survival without RV dysfunction.
Impact: Provides real-time cardiopulmonary mechanistic insights into proning in C-ARDS and identifies compliance as a potential prognostic marker.
Clinical Implications: TEE-based monitoring during prone positioning may help detect RV stress and guide ventilation strategies; targeting improved static compliance could be associated with better outcomes.
Key Findings
- Prone positioning was associated with decreased RVEDA/LVEDA and increased TAPSE on TEE.
- Oxygenation improved during prone positioning.
- Physiologic improvements did not consistently increase survival; higher Cstat correlated with better survival without RV dysfunction.
Methodological Strengths
- Prospective design with serial TEE assessments around prone positioning.
- Objective echocardiographic RV indices (RVEDA/LVEDA, TAPSE) and physiologic endpoints.
Limitations
- Small single-center sample (n=30) limits generalizability and statistical power.
- COVID-19-specific ARDS cohort; survival analysis details limited in abstract.
Future Directions: Validate TEE-derived RV metrics and compliance targets in larger multicenter cohorts and test TEE-guided ventilation strategies in ARDS.
OBJECTIVE: To evaluate the cardiopulmonary effect during prone position (PP) on right ventricular (RV) recovery in coronavirus disease-2019 related acute respiratory distress syndrome (C-ARDS) through transesophageal echocardiography (TEE). METHODS: This prospective study included 30 moderate-to-severe C-ARDS patients who were treated with PP in the first 48 h of invasive mechanical ventilation support. It was evaluated with TEE three times: before PP (T RESULTS: With the cardiopulmonary effect of PP, the decrease in RVEDA/LVEDA, the increase in TAPSE, PaO CONCLUSION: PP can improve RV recovery and oxygenation, but it isn't always accompanied by increased survival. An increase in the Cstat may improve survival without the development of RV dysfunction while maintaining heart-lung interaction.